<< Phase 1 data of ARIAD Pharmaceuticals' pan-BCR-ABL inhibitor to be presented at the ASH meeting | MMR Information Systems to add new feature in its personal health record website >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Norsk | Русский | Svenska | Polski

Lannett CEO to participate in NYSE opening bell ringing ceremony

Published on November 23, 2009 at 8:10 AM · No Comments

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that President and Chief Executive Officer Arthur Bedrosian will ring the opening bell at the New York Stock Exchange at 9:30 a.m. Eastern on Monday, November 23, 2009.

“It is a privilege to celebrate Lannett’s continuing success by participating in the NYSE opening bell ringing ceremony,” said Bedrosian. “Our financial performance over the last several quarters has been strong and we have taken actions to further grow the company, including advancing our pain management business and increasing our investment in research and development to add to our growing product offering and further diversify our portfolio.”

Source: Lannett Company, Inc.

Posted in:

Tags:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading